 |
|
Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease
Jung-Woo Rhim, Jin-Han Kang, Kyung-Yil Lee
Clin Exp Pediatr. 2022;65(4):153-166. Published online 2021 Nov 23 DOI: https://doi.org/10.3345/cep.2021.01270
|
|
Citations to this article as recorded by
 Research trends on causes of Kawasaki disease in the COVID-19 era: focus on viral infections
Young Hwan Lee
Clinical and Experimental Pediatrics.2023; 66(1): 1. CrossRef How multisystem inflammatory syndrome in children discriminated from Kawasaki disease: a differentiating score based on an inception cohort study
Ali Sobh, Doaa Mosad Mosa, Nada Khaled, Mai S. Korkor, Mohamed Ahmed Noureldin, Ahmad M. Eita, Marwa H. Elnagdy, Mohammed A. El-Bayoumi
Clinical Rheumatology.2023; 42(4): 1151. CrossRef The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children
Maodong Leng, Junmei Yang, Juanjuan Zhou
Frontiers in Pediatrics.2023;[Epub] CrossRef Analysis of cytokine levels, cytological findings, and MP‐DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia
Fang Deng, Huiling Cao, Xiaohua Liang, Qubei Li, Yang Yang, Zhihua Zhao, Junjie Tan, Guo Fu, Chang Shu
Immunity, Inflammation and Disease.2023;[Epub] CrossRef Classification and epidemiology of vasculitis: Emerging concepts
Tegwen Ecclestone, Richard A. Watts
Best Practice & Research Clinical Rheumatology.2023; 37(1): 101845. CrossRef Multisystem inflammatory syndrome in children and Kawasaki disease; comparison of their clinical findings and one-year follow-up—a cross-sectional study
Saghar Mehrban, Fatemeh Tahghighi, Ehsan Aghaei Moghadam, Vahid Ziaee
Italian Journal of Pediatrics.2023;[Epub] CrossRef Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity
Isabel Gutiérrez-Díaz, Miriam Sanz-Martinez, Ana Mª Castro, Marta Velasco Rodríguez-Belvís, Nathalie Carreira, Santiago Jiménez, Carmen Mangas, Macarena Queralt, Marta Herrador, Rafael Martín-Masot, Pablo Ferrer, Víctor M. Navas-López, Beatriz Espín, Rosa
European Journal of Pediatrics.2023; 182(10): 4633. CrossRef Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
Jiaying Chen, Jian Liao, Lupeng Xiang, Shilong Zhang, Yajing Yan
Frontiers in Immunology.2023;[Epub] CrossRef Estudio clínico-epidemiológico de Enfermedad de Kawasaki antes y durante la pandemia por COVID-19. IAHULA. 2010-2022
Dery Serna, Lyna Sierra, José de Jesús Goyo
Boletín Venezolano de Infectología.2023;[Epub] CrossRef Cerebral Venous Sinus Thrombosis following COVID-19 Vaccination: Analysis of 552 Worldwide Cases
Cesare de Gregorio, Luigi Colarusso, Giuseppe Calcaterra, Pier Paolo Bassareo, Antonio Ieni, Anna Teresa Mazzeo, Giuseppe Ferrazzo, Alberto Noto, Ioanna Koniari, Jawahar L. Mehta, Nicholas G. Kounis
Vaccines.2022; 10(2): 232. CrossRef A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children
Philip A. Wessels, Michael A. Bingler
Progress in Pediatric Cardiology.2022; : 101516. CrossRef Common immunopathogenesis of central nervous system diseases: the protein-homeostasis-system hypothesis
Kyung-Yil Lee
Cell & Bioscience.2022;[Epub] CrossRef Analysis of Gene Single Nucleotide Polymorphisms in COVID-19 Disease Highlighting the Susceptibility and the Severity towards the Infection
Mario Balzanelli, Pietro Distratis, Rita Lazzaro, Van Pham, Toai Tran, Gianna Dipalma, Angelica Bianco, Emilio Serlenga, Sergey Aityan, Valentina Pierangeli, Kieu Nguyen, Francesco Inchingolo, Diego Tomassone, Ciro Isacco
Diagnostics.2022; 12(11): 2824. CrossRef
|